Flinton Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	$760K	Buy	8,432 +208	+3%	+$18.7K	0.02%	354
2019 Q2	$694K	Buy	8,224 +4,832	+142%	+$408K	0.02%	397
2019 Q1	$299K	Buy	3,392 +800	+31%	+$70.5K	0.01%	594
2018 Q4	$185K	Buy	+2,592	New	+$185K	0.01%	668